Working… Menu

Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01365065
Recruitment Status : Unknown
Verified April 2017 by Bayside Health.
Recruitment status was:  Active, not recruiting
First Posted : June 3, 2011
Last Update Posted : April 25, 2017
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Bayside Health